The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer
出版年份 2013 全文链接
标题
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer
作者
关键词
Breast cancer, Chemo-naïve, Ki67, Prognostic index, Proliferation
出版物
SpringerPlus
Volume 2, Issue 1, Pages 111
出版商
Springer Nature
发表日期
2013-03-15
DOI
10.1186/2193-1801-2-111
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study
- (2012) Anna-Karin Falck et al. BMC CANCER
- Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer
- (2012) Elisabetta Munzone et al. BREAST CANCER RESEARCH AND TREATMENT
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
- (2011) Elisabeth Luporsi et al. BREAST CANCER RESEARCH AND TREATMENT
- Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer
- (2011) Carina Strand et al. BREAST CANCER RESEARCH AND TREATMENT
- The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase
- (2011) Emiel Rutgers et al. EUROPEAN JOURNAL OF CANCER
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups
- (2010) Mohammed A. Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer
- (2009) Marie Klintman et al. MODERN PATHOLOGY
- The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
- (2008) Robin L. Jones et al. BREAST CANCER RESEARCH AND TREATMENT
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
- (2008) C. Desmedt et al. CLINICAL CANCER RESEARCH
- Trial Assessing Individualized Options for Treatment for breast cancer: the TAILORx trial
- (2008) Jo Anne Zujewski et al. Future Oncology
- Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer
- (2008) Giuseppe Viale et al. JNCI-Journal of the National Cancer Institute
- Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics
- (2008) M. J. Ellis et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search